Case report: Adenosquamous carcinoma of the prostate with greater than 20 month response to multimodal therapy

Adenosquamous carcinoma is an extremely rare and lethal subtype of prostate cancer affecting an estimated 0.03 per million men annually. It has been associated with prior hormone therapy for prostate adenocarcinoma. We present a case of de novo adenosquamous carcinoma of the prostate treated with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennessey, Alex, Buller, Dylan, Sama, Shashank, Girard, Eric, Clement, Jessica, Ristau, Benjamin T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906645/
https://www.ncbi.nlm.nih.gov/pubmed/31867218
http://dx.doi.org/10.1016/j.eucr.2019.101084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906645/
https://www.ncbi.nlm.nih.gov/pubmed/31867218
http://dx.doi.org/10.1016/j.eucr.2019.101084

Ejemplares similares